This study stands as a potentially very important advance -- not only in DMD, but as part of a broader quest for successful gene therapies. AccessMedicine from McGraw-Hill
Findings of a 29% greater reduction in seizures at 4 months compared with controls led an FDA advisory panel to recommend approval of DBS in the ANT for severe and refractory partial seizures with or without secondary generalization. Medscape Medical News
Results of the LEAPS trial, a head to head comparison, show similar gains in walking ability with home rehab as locomotor training but with fewer risks. Medscape Medical News
Top-line results from the ASCEND-PD trial show a greater reduction in off time with IPX066 compared with an existing treatment. br / iMedscape Medical News/i
In this latest Medscape Neurology Minute, Dr. Alan Jacobs discusses how exercise training can help improve anxiety symptoms among chronically ill patients. Medscape Neurology & Neurosurgery